[BSX] Boston Scientific Corporation


Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 21.81 Change: 0.15 (0.69%)
Ext. hours: Change: 0 (0%)

chart BSX

Refresh chart

Strongest Trends Summary For BSX

BSX is in the medium-term up 24% in 5 months. In the long-term up 50% above S&P in 2 years and up 368% in 9 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in three segments: Cardiovascular, Rhythm Management, and MedSurg. It offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products used to treat patients with atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. The company also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters to treat patients with peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat patients with non-vascular disease. In addition, it offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and tr

Fundamental Ratios
Shares Outstanding EPS0.73 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -5.61% Sales Growth - Q/Q-6.31% P/E38.01
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-1.54% ROE-3.89% ROI-1.94%
Current Ratio1.29 Quick Ratio0.91 Long Term Debt/Equity5.3 Debt Ratio0.38
Gross Margin70.26% Operating Margin-6.43% Net Profit Margin-3.43% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-94 M Cash From Investing Activities-51 M Cash From Operating Activities-197 M Gross Profit1.3 B
Net Profit102 M Operating Profit219 M Total Assets17.12 B Total Current Assets3.77 B
Total Current Liabilities1.94 B Total Debt5.11 B Total Liabilities10.54 B Total Revenue1.84 B
Technical Data
High 52 week43.2 Low 52 week31.73 Last close43.2 Last change1.03%
RSI55.54 Average true range1.01 Beta0.89 Volume4.25 M
Simple moving average 20 days1.82% Simple moving average 50 days3.23% Simple moving average 200 days12.62%
Performance Data
Performance Week1.05% Performance Month0% Performance Quart18.1% Performance Half10.23%
Performance Year25.98% Performance Year-to-date22.24% Volatility daily1.34% Volatility weekly2.99%
Volatility monthly6.12% Volatility yearly21.2% Relative Volume246.39% Average Volume6.81 M
New High New Low


2019-09-19 09:35:00 | 10 Stable Growth Stocks That Are Still Worth the Price, According to an Analyst

2019-09-18 06:45:00 | Boston Scientific Announces Scheduled Presentations at Transcatheter Cardiovascular Therapeutics 2019

2019-09-13 09:40:01 | BAX or BSX: Which Is the Better Value Stock Right Now?

2019-09-13 09:13:01 | IoMT Becomes the Buzzword in New Age MedTech Investing

2019-09-10 11:07:35 | Morgan Stanley: Buy These 3 Stocks on Recent Weakness

2019-09-10 07:13:25 | 3 Big Stock Charts for Tuesday: Boston Scientific, GM and United Airlines

2019-09-02 08:26:15 | Does Boston Scientific Corporation's NYSE:BSX CEO Pay Reflect Performance?

2019-08-26 10:47:02 | Boston Scientific Closes BTG Buyout, PI Arm to Get a Boost

2019-08-23 09:31:01 | Boston Scientific BSX Up 1.6% Since Last Earnings Report: Can It Continue?

2019-08-20 09:30:01 | BAX vs. BSX: Which Stock Is the Better Value Option?

2019-08-20 09:30:00 | Boston Scientific to Participate in the 2019 Wells Fargo Securities Healthcare Conference

2019-08-20 09:03:01 | Boston Scientific's BSX Vercise Gevia DBS Gets FDA Nod

2019-08-20 09:01:01 | Here's Why You Should Hold Varian Medical VAR Stock Now

2019-08-19 17:39:00 | Boston Scientific Announces FDA Approval Of ImageReady™ MRI For Vercise Gevia™ Deep Brain Stimulation System

2019-08-19 06:00:00 | Boston Scientific Closes Acquisition of BTG plc.

2019-08-16 09:20:01 | Teledyne Technologies, Netgear, Boston Scientific, Medtronic and Becton Dickinson highlighted as Zacks Bull and Bear of the Day

2019-08-15 10:15:02 | FDA Resets PAD Guidelines: The Road Ahead for Device Makers

2019-08-15 09:44:01 | Cardiovascular Systems Set to Present LIBERTY 360 Outcome

2019-08-15 07:58:16 | Don't Sell Boston Scientific Corporation NYSE:BSX Before You Read This

2019-08-15 05:55:48 | Bain executive joins biotech startup Cerevel's C-suite

2019-08-13 10:18:02 | Boston Scientific Rides on New Products Amid Dull Pacer Sales

2019-08-12 13:14:38 | Top Analyst Reports: Amgen, Uber, Mondelez & More

2019-08-02 13:56:40 | David Carlson Goes 2 for 2 in 2nd Quarter

2019-07-30 10:22:02 | 4 Medical Product Stocks Set to Beat This Earnings Season

2019-07-29 08:00:00 | Mayo Clinic, Boston Scientific teaming up on med-tech accelerator

2019-07-28 09:02:30 | What We Think Of Boston Scientific Corporation’s NYSE:BSX Investment Potential

2019-07-27 12:17:00 | 10 Biggest Medical Device Stocks

2019-07-25 09:30:00 | Boston Scientific to Participate in 39th Annual Canaccord Genuity Growth Conference

2019-07-24 20:24:19 | Boston Scientific BSX Q2 2019 Earnings Call Transcript

2019-07-24 18:06:55 | Edited Transcript of BSX earnings conference call or presentation 24-Jul-19 12:00pm GMT

2019-07-24 16:24:27 | Two Medtech Giants Top Earnings Views And Narrowly Hold Onto Buy Points

2019-07-24 16:00:00 | What You'll Want to Know About Boston Scientific's Q2 Earnings

2019-07-24 10:56:02 | Boston Scientific BSX Q2 Earnings Top on Growth in All Lines

2019-07-24 07:45:11 | Boston Scientific BSX Surpasses Q2 Earnings Estimates

2019-07-24 07:20:00 | Boston Scientific tops second-quarter profit expectations but misses on revenue

2019-07-24 07:05:51 | UPDATE 2-Boston Scientific's narrow profit beat fails to excite investors

2019-07-24 06:40:53 | Boston Scientific profit falls 72% on acquisition charges

2019-07-24 06:30:00 | Boston Scientific Announces Results For Second Quarter 2019

2019-07-23 17:36:36 | CEO calls it an 'important day for women's health.' Wall Street appears unimpressed

2019-07-23 13:04:00 | [video]Boston Scientific Expected to Earn 38 Cents a Share

2019-07-22 10:15:02 | What's in Store for Boston Scientific's BSX Q2 Earnings?

2019-07-18 10:42:02 | Will USTR's 25% Tariff Exemption Spell Relief for MedTech?

2019-07-17 16:19:15 | These 4 Medical Stocks Could Benefit From J&J Earnings — Here's Why

2019-07-17 10:32:02 | Earnings Preview: Boston Scientific BSX Q2 Earnings Expected to Decline

2019-07-17 08:01:12 | US-India Trade Tensions Rise: 3 Stocks in the Line of Fire

2019-07-12 08:13:12 | Tap AI-Powered Medical Device Stocks as FDA Bolsters SaMD

2019-07-11 10:58:02 | The Zacks Analyst Blog Highlights: Bank of America, Eli Lilly, Boston Scientific, Schwab and Advanced Micro Devices

2019-07-10 15:13:07 | Top Stock Reports for Bank of America, Eli Lilly & Boston Scientific

2019-07-10 11:11:03 | Boston Scientific's Global Growth Robust Amid Currency Woe

2019-07-09 08:00:59 | See what the IHS Markit Score report has to say about Boston Scientific Corp.